These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35422862)

  • 1. The Involvement of WDHD1 in the Occurrence of Esophageal Cancer as a Downstream Target of PI3K/AKT Pathway.
    Xian Q; Zhu D
    J Oncol; 2022; 2022():5871188. PubMed ID: 35422862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of WD repeat and high-mobility group box DNA binding protein 1 in pulmonary and esophageal carcinogenesis.
    Sato N; Koinuma J; Fujita M; Hosokawa M; Ito T; Tsuchiya E; Kondo S; Nakamura Y; Daigo Y
    Clin Cancer Res; 2010 Jan; 16(1):226-39. PubMed ID: 20028748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3K/Akt signalling pathway and cancer.
    Fresno Vara JA; Casado E; de Castro J; Cejas P; Belda-Iniesta C; González-Barón M
    Cancer Treat Rev; 2004 Apr; 30(2):193-204. PubMed ID: 15023437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanism.
    Wu JY; Lan XL; Yan DM; Fang YY; Peng YX; Liang FF; Jiang L; Huang SN; Mo M; Lin CX; Niu YT; Wu XW; Wei ZX
    Pathol Res Pract; 2022 Feb; 230():153751. PubMed ID: 34999279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WDHD1 facilitates G1 checkpoint abrogation in HPV E7 expressing cells by modulating GCN5.
    Zhou Y; Pei F; Ji M; Zhang F; Sun Y; Zhao Q; Wang X; Hong Y; Tian J; Wang Y; Chen JJ
    BMC Cancer; 2020 Sep; 20(1):840. PubMed ID: 32883234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-dependent Akt-ivity: where, when, and how.
    Siess KM; Leonard TA
    Biochem Soc Trans; 2019 Jun; 47(3):897-908. PubMed ID: 31147387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WD Repeat and HMG Box DNA Binding Protein 1: An Oncoprotein at the Hub of Tumorigenesis and a Novel Therapeutic Target.
    Zhang Z; Zhu Q
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.
    Cui Z; Zou F; Wang R; Wang L; Cheng F; Wang L; Pan R; Guan X; Zheng N; Wang W
    World J Surg Oncol; 2023 Sep; 21(1):309. PubMed ID: 37759234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 plays an important role in DNA replication by turning on WDHD1.
    Zhou Y; Chen JJ
    Cell Biosci; 2021 Jan; 11(1):10. PubMed ID: 33413624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.
    Zhou Y; Zhang Q; Gao G; Zhang X; Liu Y; Yuan S; Wang X; Chen JJ
    J Virol; 2016 Jul; 90(13):6071-6084. PubMed ID: 27099318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI(3,4)P2 Signaling in Cancer and Metabolism.
    Gozzelino L; De Santis MC; Gulluni F; Hirsch E; Martini M
    Front Oncol; 2020; 10():360. PubMed ID: 32296634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer.
    Jiang Y; Yu Z; Zheng H; Zhou X; Zhou M; Geng X; Zhu Y; Huang S; Gong Y; Guo L
    Aging (Albany NY); 2024 Jul; 16(13):10813-10831. PubMed ID: 38980253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.
    Huang R; Dai Q; Yang R; Duan Y; Zhao Q; Haybaeck J; Yang Z
    Front Oncol; 2022; 12():817916. PubMed ID: 35574327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WDHD1 is over-expressed in nasopharyngeal carcinoma and may control the expression of ITGAV.
    Wu JY; Niu YT; Huang SN; Tan YM; Yang ZD; Fang YY; Jiang L; Zhang TT; Zeng XF; Peng YX; Mo M; Lin CX; Wei ZX
    FEBS Open Bio; 2023 Jan; 13(1):102-117. PubMed ID: 36345604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Expression and Prognostic Impact of the PI3K/AKT/mTOR Signaling Pathway in Advanced Esophageal Squamous Cell Carcinoma.
    Wu N; Du Z; Zhu Y; Song Y; Pang L; Chen Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818758772. PubMed ID: 29463194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders.
    Chen J; Alberts I; Li X
    Int J Dev Neurosci; 2014 Jun; 35():35-41. PubMed ID: 24662006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
    Liang Y; Li S
    Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma.
    Zhang X; Zou N; Deng W; Song C; Yan K; Shen W; Zhu S
    Mol Biol Rep; 2022 Dec; 49(12):11933-11945. PubMed ID: 36260180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Interplay between Calmodulin and Membrane Interactions with the Pleckstrin Homology Domain of Akt.
    Agamasu C; Ghanam RH; Xu F; Sun Y; Chen Y; Saad JS
    J Biol Chem; 2017 Jan; 292(1):251-263. PubMed ID: 27872186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.
    Chiarini F; Falà F; Tazzari PL; Ricci F; Astolfi A; Pession A; Pagliaro P; McCubrey JA; Martelli AM
    Cancer Res; 2009 Apr; 69(8):3520-8. PubMed ID: 19351820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.